Nexus AG commences an Equity Buyback Plan for 1,727,469 shares, representing 10% of its issued share capital, under the authorization approved on May 16, 2023.
July 24, 2023
Share
Nexus AG (XTRA:NXU) commences share repurchases on July 25, 2023, under the program mandated by the shareholders in the Annual General Meeting held on May 16, 2023. As per the mandate, the company is authorized to repurchase up to 1,727,469 shares, representing 10% of the issued share capital. The repurchases will be made at a price which may not exceed the average closing price of XETRA trading or a comparable successor system at the Frankfurt/Main Stock Exchange for the company's shares during the last five trading days prior to acquisition of the shares by no more than 10%. If repurchases are made through public offer, the offered purchase price or the limit values of the offered purchase price rate per share (excluding incidental purchase costs) may not exceed the average price of the closing rates in XETRA trade (or a comparable follow-up system) at the Frankfurt/Main Securities Market for the stocks of the company during the last five stock market days before publication of the purchase offer by more than 10% nor may they be more than 10% below these prices. The repurchased shares will be used for capital reduction, can be resold, can be issued to employees and pensioners of the company as well as to employees and pensioners of the companies affiliated with it, can be offered to a third party within the context of company mergers or at purchase of companies, parts of company or participating shares in companies. The repurchase program is valid until April 30, 2028. As of April 4, 2023, the company had 17,274,695 issued shares and 35,439 treasury shares.
On July 24, 2023, the company announced a share repurchase program. Under the program, the company will repurchase up to 300,000 shares for ?24 million.
Nexus AG is a Germany-based developer of software for the health care sector. Among others, the Company provides Nexus/HIS, an information system that supports the administrative and medical/nursing areas in hospitals; Nexus/Obstetrics, a documentation software for pregnancies; is also focusing on digital pathology which controls the processes from material entry to billing; Nexus/Psychiatry, a solution for psychiatric institutions from treating patients to key figure management for institution management; CWD - Clinic WindData (E&L), a diagnostics software for the areas of endoscopy, cardiology, sonography and ophthalmology; Nexus/Home, an information system that features finance, resident and treatment management, as well as staff deployment, and Nexus/Curator, a Web-based knowledge database for quality management with document management in health care. The Company operates through subsidiaries in Austria, France, Spain, Switzerland, the Netherlands and Poland, among others.
Nexus AG commences an Equity Buyback Plan for 1,727,469 shares, representing 10% of its issued share capital, under the authorization approved on May 16, 2023.
NEXUS AG 
